Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Novo Nordisk launches recycling for injection pens with community pharmacies playing key role

Novo Nordisk has launched PenCycle, a recycling initiative for pre-filled injection pens, designed to address the challenge of recycling injection pen devices.

A first-of-its-kind scheme in the UK, covering FlexPen® and FlexTouch® used to dispense insulin and other medications, will have community pharmacies playing a key role.


Users can return their devices to local participating community pharmacies or through pre-paid Royal Mail boxes or use an ‘at home’ collection pilot service for growth hormone pens.

The pens will then be returned to Denmark where the plastic will be recycled into a range of items, such as chairs and lamps, the Danish multinational pharmaceutical company said.

PenCycle return box

As part of the initiative, participating pharmacies will be provided a PenCycle Starter Pack, containing all necessary materials, including practical guidance on the initiative, patient information and materials for patients to take home and start PenCycling.

The pilot will launch initially across Greater Manchester, Leicestershire & Rutland, and Greater Glasgow and Clyde, ahead of a planned national roll-out next year.

The pilot alone aims to recycle over 150,000 pre-filled plastic injection pen devices, ensuring over two tonnes of plastic material is diverted from the UK landfill.

By the end of 2022, it aims to recycle 1.1 million pen devices.

According to the company, the project has a potential to recycle over 3 million pen devices in 2023, preventing over 56 tonnes of plastic waste.

Pinder Sahota, general manager UK, Novo Nordisk said: “As part of our Circular for Zero initiative, we were the first pharmaceutical company to run all of our production through renewable power, and now we are taking on the challenge of recycling our plastic pen devices.

"To provide convenient options to people we have focused on establishing partnerships with community pharmacies and the Royal Mail.

“Through this recycling initiative we can help to give used pens a new purpose, and play our part in preventing further waste.”

Laura Sims, head of membership for the National Pharmacy Association, said: “We’re pleased to be supporting the PenCycle collaboration, and helping our members understand the benefits of the pilot scheme and how to take part.

"Community pharmacies dispense more than a billion prescription items each year and can greatly increase sustainability through recycling.”

Expressing delight over supporting the PenCycle initiative, Kevin Birch, chief retail officer at LloydsPharmacy, said his company is "committed to becoming a sustainable business, and we understand that our customers and patients expect us to play our part. Reducing plastic waste in our healthcare settings is a key part of our approach.”

More For You

Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Trump signs executive order to accelerate US-based pharmaceutical manufacturing plants

US president Donald Trump

Pic credit: Getty Images

Trump signs executive order to encourage US drug manufacturing

US president Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.

The order directs the US Food and Drug Administration to streamline reviews and work with domestic manufacturers to provide early support before facilities come online.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less
NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less